Article Details

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic ... - PR Newswire

Retrieved on: 2022-05-12 10:03:09

Tags for this article:

Click the tags to see associated articles and topics

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic ... - PR Newswire. View article details on hiswai:

Excerpt

PRNewswire/ -- Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up